MSC therapy for diabetic kidney disease and nephrotic syndrome

Rožanc, J. et al. Mesenchymal stem cells isolated from paediatric paravertebral adipose tissue show strong osteogenic potential. Biomedicines 10, 378 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Perico, N. et al. Safety and preliminary efficacy of mesenchymal stromal cell (ORBCEL-M cell) therapy in diabetic kidney disease: a randomized clinical trial (NEPHSTROM). J. Am. Soc. Nephrol., https://doi.org/10.1681/ASN.0000000000000189 (2023).

Article  PubMed  Google Scholar 

Vivarelli, M. et al. A phase 1 study of autologous mesenchymal stromal cells for severe steroid-dependent nephrotic syndrome. JCI Insight 8, e169424 (2023).

Article  PubMed  Google Scholar 

Packham, D. K., Fraser, I. R., Kerr, P. G. & Segal, K. R. Allogeneic mesenchymal precursor cells (MPC) in diabetic nephropathy: a randomized, placebo-controlled, dose escalation study. EBioMedicine 12, 263–269 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Morello, W. et al. First clinical application of cord blood mesenchymal stromal cells in children with multi-drug resistant nephrotic syndrome. Stem Cell Res. Ther. 13, 420 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Thompson, M. et al. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta-analysis. EClinicalMedicine 19, 100249 (2020).

Article  PubMed  PubMed Central  Google Scholar 

Wu, Z. et al. Thromboembolism induced by umbilical cord mesenchymal stem cell infusion: a report of two cases and literature review. Transplant. Proc. 49, 1656–1658 (2017).

Article  CAS  PubMed  Google Scholar 

Starc, N. et al. Phenotypic and functional characterization of mesenchymal stromal cells isolated from pediatric patients with severe idiopathic nephrotic syndrome. Cytotherapy 20, 322–334 (2018).

Article  CAS  PubMed  Google Scholar 

Joswig, A. J. et al. Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model. Stem Cell Res. Ther. 8, 42 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Liau, L. L., Ruszymah, B. H. I., Ng, M. H. & Law, J. X. Characteristics and clinical applications of Wharton’s jelly-derived mesenchymal stromal cells. Curr. Res. Transl. Med. 68, 5–16 (2020).

CAS  PubMed  Google Scholar 

Comments (0)

No login
gif